Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Dr Horton (DHI) stocks in Canada

Learn how to easily invest in Dr Horton stocks.

Dr Horton is a residential construction business based in the US. Dr Horton stocks (DHI.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $106.96 – a decrease of 0.97% over the previous week. Dr Horton employs 11,788 staff and has a trailing 12-month revenue of around $27.8 billion.

How to buy shares in Dr Horton

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DHI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Dr Horton stock price (NYSE:DHI)

Use our graph to track the performance of DHI stocks over time.

Dr Horton shares at a glance

Information last updated 2022-01-24.
Latest market close$89.45
52-week range$72.12 - $110.45
50-day moving average $101.43
200-day moving average $94.37
Wall St. target price$120.68
PE ratio 7.7607
Dividend yield $0.8 (1.02%)
Earnings per share (TTM) $11.41

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Dr Horton stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Dr Horton price performance over time

Historical closes compared with the close of $89.45 from 2022-01-25

1 week (2022-01-15) N/A
1 month (2021-12-22) N/A
3 months (2021-10-26) 0.85%
6 months (2021-07-26) -3.32%
1 year (2021-01-26) 14.99%
2 years (2020-01-24) 52.88%
3 years (2019-01-25) 139.81%
5 years (2017-01-26) 185.33%

Is Dr Horton under- or over-valued?

Valuing Dr Horton stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dr Horton's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Dr Horton's P/E ratio

Dr Horton's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Dr Horton shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Dr Horton's PEG ratio

Dr Horton's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.7968. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dr Horton's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Dr Horton's EBITDA

Dr Horton's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.5 billion.

The EBITDA is a measure of a Dr Horton's overall financial performance and is widely used to measure a its profitability.

Dr Horton financials

Revenue TTM $27.8 billion
Operating margin TTM 19.36%
Gross profit TTM $7.4 billion
Return on assets TTM 15.66%
Return on equity TTM 30.66%
Profit margin 15.04%
Book value $41.81
Market capitalisation $31.5 billion

TTM: trailing 12 months

Dr Horton's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Dr Horton.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Dr Horton's total ESG risk score

Total ESG risk: 28

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Dr Horton's overall score of 28 (as at 01/01/2019) is pretty good – landing it in it in the 32nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Dr Horton is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Dr Horton's environmental score

Environmental score: 13.47/100

Dr Horton's environmental score of 13.47 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Dr Horton is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Dr Horton's social score

Social score: 15.42/100

Dr Horton's social score of 15.42 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Dr Horton is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Dr Horton's governance score

Governance score: 14.6/100

Dr Horton's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Dr Horton is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Dr Horton's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Dr Horton scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Dr Horton has, for the most part, managed to keep its nose clean.

Dr Horton share dividends

7%

Dividend payout ratio: 7.17% of net profits

Recently Dr Horton has paid out, on average, around 7.17% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Dr Horton shareholders could enjoy a 1.02% return on their shares, in the form of dividend payments. In Dr Horton's case, that would currently equate to about $0.8 per share.

While Dr Horton's payout ratio might seem low, this can signify that Dr Horton is investing more in its future growth.

Dr Horton's most recent dividend payout was on 15 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 3 December 2021 (the "ex-dividend date").

Have Dr Horton's shares ever split?

Dr Horton's shares were split on a 4:3 basis on 17 March 2005. So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Dr Horton shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Dr Horton shares which in turn could have impacted Dr Horton's share price.

Dr Horton share price volatility

Over the last 12 months, Dr Horton's shares have ranged in value from as little as $72.1158 up to $110.45. A popular way to gauge a stock's volatility is its "beta".

DHI.US volatility(beta: 1.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Dr Horton's is 1.633. This would suggest that Dr Horton's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Dr Horton overview

D. R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 31 states and 98 markets under the names of D. R. Horton, America's Builder, Express Homes, Emerald Homes, and Freedom Homes.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site